Condor Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Condor Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,750	Closed	-$128K	–	258
2022 Q4	$128K	Hold	12,750	–	–	0.02%	224
2022 Q3	$126K	Hold	12,750	–	–	0.02%	217
2022 Q2	$125K	Sell	12,750 -240	-2%	-$2.35K	0.02%	209
2022 Q1	$127K	Buy	12,990 +10,230	+371%	+$99.5K	0.01%	214
2021 Q4	$27K	Hold	2,760	–	–	﹤0.01%	279
2021 Q3	$27K	Buy	2,760 +2,000	+263%	+$19.3K	﹤0.01%	247
2021 Q2	$7K	Buy	+760	New	+$7.43K	﹤0.01%	291

Condor Capital Management's MSAC Position: Q1 2023 in Review

Condor Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 12,750 shares — an estimated $128K sold.

Condor Capital Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $128K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Condor Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Condor Capital Management sold 12,750 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $128K.
Condor Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Condor Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $128K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Condor Capital Management's 13F filing for Q1 2023, filed 10 May 2023.